GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPX International Corp (STU:2J6) » Definitions » Debt-to-Asset

MPX International (STU:2J6) Debt-to-Asset : 0.54 (As of Mar. 2022)


View and export this data going back to 2019. Start your Free Trial

What is MPX International Debt-to-Asset?

MPX International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €5.95 Mil. MPX International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €12.18 Mil. MPX International's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2022 was €33.81 Mil. MPX International's debt to asset for the quarter that ended in Mar. 2022 was 0.54.


MPX International Debt-to-Asset Historical Data

The historical data trend for MPX International's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPX International Debt-to-Asset Chart

MPX International Annual Data
Trend Sep18 Sep19 Sep20 Sep21
Debt-to-Asset
0.04 0.03 0.21 0.37

MPX International Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.30 0.37 0.42 0.54

Competitive Comparison of MPX International's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MPX International's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where MPX International's Debt-to-Asset falls into.



MPX International Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

MPX International's Debt-to-Asset for the fiscal year that ended in Sep. 2021 is calculated as

MPX International's Debt-to-Asset for the quarter that ended in Mar. 2022 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(5.949 + 12.176) / 33.805
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MPX International  (STU:2J6) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


MPX International Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of MPX International's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


MPX International (STU:2J6) Business Description

Traded in Other Exchanges
N/A
Address
5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.

MPX International (STU:2J6) Headlines

No Headlines